Fevertreeman. Mr Newland clearly believes the Parsortix21 Jun 2024 17:09
Device (that can catch circulating tumour cells, 99% of them still alive, from blood for analysis) is key to generating 10's it not hundreds of millions of pounds. I see him as an excellent salesman. I mean he's sold millions of pounds of Angle Shares to you, me, and thousands of others! Many are understandably upset that they bought into the placing in 2022 @ 80p. The directors at that time thought the Parsortix machines would "fly off the shelves" and clearly, they did not. However, all in not lost. Far from it. 290 machines are out there and each time a tube of blood is processed a new cassette is needed @ what..... $200 a go? It's likely that to promote Parsortix some machines were sold for a minimum fee, with x amount of cassettes also for next to no cost. Once the cheap cassettes run out then, assuming they don't stop using it (which seems unlikely) a steady revenue flow should appear if it has not already. We should not forget 99% of the CTC's Parsortix catches are alive and so perfect for Analysis. Not only the DNA, but the proteins and RNA too. CtDna analysis of blood only offers the DNA for analysis. The proteins and RNA are simply not there. This is why the likes of Astrazeneca and Eisai have placed orders with Angle Plc and IMHO a lot, lot more will follow in time.
All IMHO.